Deep brain stimulation of the superolateral medial forebrain bundle in obsessive-compulsive disorder: Outcomes of symptom domains and their predictive value for treatment efficacy
- 1Department of Psychiatry and Psychotherapy, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 2Department of Stereotactic and Functional Neurosurgery, Medical Center of Freiburg University and Medical Faculty of Freiburg University, Freiburg, Germany
Abstract
Deep Brain Stimulation (DBS) of the superolateral medial forebrain bundle (slMFB) has shown promise in treatment-resistant obsessive-compulsive disorder (OCD). However, little is known about whether specific symptom domains respond better to the intervention or whether they may predict overall treatment outcomes. This study evaluated the effects of slMFB DBS on self-reported obsessive-compulsive symptom domains and investigated whether baseline symptom domains predict clinical response. Fourteen patients with treatment-resistant OCD received slMFB DBS. Symptom severity was assessed with the Obsessive-Compulsive Inventory-Revised (OCI-R) and the Yale-Brown Obsessive-Compulsive Scale at multiple postoperative time points. Linear mixed-effects models examined longitudinal changes, and stepwise multiple regression analyses tested whether baseline symptom proportions predicted treatment response. OCI-R total scores decreased significantly over time (F = 16.80, p < .001, pFDR = .004), with large effect sizes (d = −1.19 at last follow-up). Subscale analyses revealed the greatest improvements in obsessing, checking, and ordering. Regression analyses identified the baseline proportion of obsessing symptoms as a significant predictor of outcome (β = 0.55, p = .043, R2 = 0.30). slMFB DBS yields substantial improvement in self-reported obsessive-compulsive symptoms, particularly in patients with prominent obsessional features. Obsession-dominant profiles may predict superior response, supporting a phenotype-guided approach to neuromodulation in OCD.
Related
- Patient-specific subnetwork connectivity predicts deep brain stimulation response in obsessive-compulsive disorder
- Assessing the effect of subthalamic stimulation on metaperception in obsessive-compulsive disorder
- Long-term outcomes of nucleus accumbens/anterior limb of the internal capsule deep brain stimulation in treatment-resistant obsessive-compulsive disorder
- Reduced cortical thickness in obsessive-compulsive disorder and candidate molecular correlates
- Intensive cognitive behavioral therapy for obsessive-compulsive disorder: a meta-analysis of randomized controlled trials
BibTeX
@article{czornik2026deep,
title = {{Deep brain stimulation of the superolateral medial forebrain bundle in obsessive-compulsive disorder: Outcomes of symptom domains and their predictive value for treatment efficacy}},
author = {Manuel Czornik and Thomas E. Schlaepfer and Lea Zöllner and Dora M. Meyer-Doll and Selina Rolker and Bastian E.A. Sajonz and Katharina Domschke and Dominique Endres and Kimon Runge and Volker A. Coenen and Juan Carlos Baldermann},
journal = {Neurotherapeutics},
year = {2026},
month = oct,
doi = {10.1016/j.neurot.2026.e01094},
url = {https://doi.org/10.1016/j.neurot.2026.e01094},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Deep brain stimulation of the superolateral medial forebrain bundle in obsessive-compulsive disorder: Outcomes of symptom domains and their predictive value for treatment efficacy
AU - Manuel Czornik
AU - Thomas E. Schlaepfer
AU - Lea Zöllner
AU - Dora M. Meyer-Doll
AU - Selina Rolker
AU - Bastian E.A. Sajonz
AU - Katharina Domschke
AU - Dominique Endres
AU - Kimon Runge
AU - Volker A. Coenen
AU - Juan Carlos Baldermann
PY - 2026
DA - 2026/10/30
JO - Neurotherapeutics
DO - 10.1016/j.neurot.2026.e01094
UR - https://doi.org/10.1016/j.neurot.2026.e01094
AB - Deep Brain Stimulation (DBS) of the superolateral medial forebrain bundle (slMFB) has shown promise in treatment-resistant obsessive-compulsive disorder (OCD). However, little is known about whether specific symptom domains respond better to the intervention or whether they may predict overall treatment outcomes. This study evaluated the effects of slMFB DBS on self-reported obsessive-compulsive symptom domains and investigated whether baseline symptom domains predict clinical response. Fourteen patients with treatment-resistant OCD received slMFB DBS. Symptom severity was assessed with the Obsessive-Compulsive Inventory-Revised (OCI-R) and the Yale-Brown Obsessive-Compulsive Scale at multiple postoperative time points. Linear mixed-effects models examined longitudinal changes, and stepwise multiple regression analyses tested whether baseline symptom proportions predicted treatment response. OCI-R total scores decreased significantly over time (F = 16.80, p < .001, pFDR = .004), with large effect sizes (d = −1.19 at last follow-up). Subscale analyses revealed the greatest improvements in obsessing, checking, and ordering. Regression analyses identified the baseline proportion of obsessing symptoms as a significant predictor of outcome (β = 0.55, p = .043, R2 = 0.30). slMFB DBS yields substantial improvement in self-reported obsessive-compulsive symptoms, particularly in patients with prominent obsessional features. Obsession-dominant profiles may predict superior response, supporting a phenotype-guided approach to neuromodulation in OCD.
SN - 1933-7213
SN - 1878-7479
ER -